Abbott India balance sheet

As of Mar 2026

Total assets: ₹6,502cr+9.9% on Mar 2025
Shareholders' equity: ₹4,774cr+12.8% on Mar 2025
Cash and investments: ₹442cr−21.1% on Mar 2025
Cash from operations: ₹1,319cr+30.4% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	328	330	218	229
	5.5	18.1	10.1	3.7
	3.8	6.5	6.7	7.5
	2,348	755	1,657	1,222
	2,348	—	—	—
	26.0	15.0	15.9	16.9
	1.1	3.9	1.0	1.6
	2,731	1,152	1,948	1,530
	947	882	620	649
	362	380	319	317
	442	561	292	240
	1,813	1,067	1,843	1,697
	131	1,782	94.6	70.5
	2,748	3,790	2,548	2,324
	75.6	69.6	78.1	51.8
	3,771	4,765	3,246	3,025
	6,502	5,917	5,193	4,556
Equity
	21.3	21.3	21.3	21.3
	4,753	4,212	3,678	3,167
	4,774	4,233	3,699	3,189
	4,774	4,233	3,699	3,189
Liabilities
	118	119	115	93.5
	251	277	152	161
	1,082	—	18.0	18.0
	88.6	80.9	74.9	78.0
	201	168	137	126
	13.0	19.7	11.5	10.5
	28.8	41.9	70.5	53.6
	1,477	1,407	1,343	1,206
	1,728	1,684	1,495	1,367
	6,502	5,917	5,193	4,556

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ABBOTINDIA₹26,275.00

Abbott India Ltd.

· Pharma & Health

₹ CrorePeersPFIZER GLAXO IPCALAB AJANTPHARM ANTHEM MEDANTA GLENMARK BIOCON

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	229.4	218.3	329.5	327.5
+ Capital Work-in-Progress	3.7	10.1	18.1	5.5
+ Other Intangibles	7.5	6.7	6.5	3.8
+ Other Non-current Financial Assets	1,222.1	1,656.5	754.7	2,347.6
Non-current Financial Assets	—	—	—	2,347.6
+ Deferred Tax Assets	16.9	15.9	15.0	26.0
+ Other Non-current Assets	1.6	1.0	3.9	1.1
Total Non-current Assets	1,530.4	1,947.7	1,152.2	2,731.2
Current Assets
+ Inventories	648.9	619.6	882.0	947.3
+ Trade Receivables	317.0	319.1	380.2	361.7
+ Cash & Cash Equivalents	239.7	291.7	560.6	442.3
+ Other Bank Balances	1,697.4	1,842.8	1,067.3	1,812.6
+ Other Current Financial Assets	70.5	94.6	1,781.8	131.2
Current Financial Assets	2,324.5	2,548.2	3,790.0	2,747.8
+ Other Current Assets	51.8	78.1	69.6	75.6
Total Current Assets	3,025.1	3,245.8	4,765.1	3,770.7
Total Assets	4,555.5	5,193.5	5,917.3	6,501.9
Equity
+ Equity Share Capital	21.3	21.3	21.3	21.3
+ Other Equity / Reserves	3,167.3	3,677.6	4,211.9	4,752.9
Equity — Owners of Parent	3,188.5	3,698.9	4,233.2	4,774.2
Total Equity	3,188.5	3,698.9	4,233.2	4,774.2
Liabilities
+ Provisions — Non-current	93.5	115.1	119.2	117.5
Non-current Liabilities	161.0	151.9	277.0	251.2
+ Trade Payables	18.0	18.0	—	1,082.3
+ Other Current Financial Liab	78.0	74.9	80.9	88.6
+ Provisions — Current	126.2	136.8	168.0	200.9
+ Current Tax Liabilities	10.5	11.5	19.7	13.0
+ Other Current Liabilities	53.6	70.5	41.9	28.8
Current Liabilities	1,206.0	1,342.7	1,407.2	1,476.6
Total Liabilities	1,367.0	1,494.6	1,684.2	1,727.7
Total Equity & Liabilities	4,555.5	5,193.5	5,917.3	6,501.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.